Series B · Medtech & Devices · Paris, France · Founded 2014 · 35–45 employees
Sensome is a French medtech startup developing breakthrough tissue-sensing technology that transforms invasive medical devices into connected healthcare devices. Their proprietary micro-sensor technology uses electrical impedance spectroscopy to identify biological tissue composition in real-time during minimally invasive procedures. The company's flagship product, Clotild, is a smart neurovascular guidewire that helps physicians treat acute ischemic strokes more effectively by providing instant clot composition analysis. Founded in 2014, Sensome has raised approximately €18.3 million across multiple funding rounds and has established a strategic partnership with Japanese medical device manufacturer Asahi Intecc for commercialization.
No open roles listed right now.